BREAKINGON

FDA Reverses Layoffs: Employees Called Back to Work

2/22/2025
In a surprising move, the FDA is reversing termination notices for some employees laid off recently, as part of a response to President Trump's executive order to reduce the federal workforce.
FDA Reverses Layoffs: Employees Called Back to Work
Discover how the FDA is rescinding layoff notices for some workers following President Trump's order to downsize the federal workforce. Find out more about the impact on health agencies and the affected employees.

FDA Reverses Termination Notices for Some Laid-Off Employees

The Food and Drug Administration (FDA) has begun reversing termination notices for certain employees who were laid off recently. On Friday evening and into Saturday morning, these employees, who are considered probationary, received calls from the FDA's human resources department. According to three anonymous sources familiar with these communications, the agency assured the affected workers that they would regain computer and network access by Monday.

Impact on the Center for Devices and Radiological Health

Among those who received calls were former employees from the Center for Devices and Radiological Health. This office, which is pivotal in overseeing medical devices and digital health products, reportedly faced significant layoffs. The device industry quickly responded with opposition to these mass firings.

It remains uncertain how many terminations will ultimately be reversed, as some FDA employees are expected to return to their offices starting Monday. Both the FDA and the US Department of Health and Human Services have yet to issue a statement regarding this situation.

Background on Federal Workforce Reductions

The callback initiative follows the termination of thousands of federal employees due to an executive order from President Donald Trump that aimed to reduce the federal workforce. This wave of layoffs began shortly after the executive order, impacting various health agencies such as the Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), and the Centers for Medicare & Medicaid Services, among other branches within the Department of Health and Human Services (HHS).

Details of the FDA's Termination Notices

The FDA's termination notices specifically targeted employees under a probationary period. The notices indicated that these employees were "not fit for continued employment" because their "ability, knowledge, and skills do not fit the Agency's current needs." This information was gleaned from an email sent by acting chief human capital officer Jeffery Anoka, as reported by Bloomberg Law.

According to the email, affected employees were to be placed on administrative leave and would receive four weeks of pay. The reversal of some of these terminations indicates a re-evaluation of the agency's staffing needs in light of recent industry feedback and operational requirements.

Breakingon.com is an independent news platform that delivers the latest news, trends, and analyses quickly and objectively. We gather and present the most important developments from around the world and local sources with accuracy and reliability. Our goal is to provide our readers with factual, unbiased, and comprehensive news content, making information easily accessible. Stay informed with us!
© Copyright 2025 BreakingOn. All rights reserved.